CELL INTELLIGENCE · 肿瘤细胞治疗研究

新型 PSCA 靶向衔接分子用于前列腺癌晚期 RevCAR-T 细胞治疗

Novel PSCA-Targeting Adapter Molecules for Late-Stage RevCAR-T Cell Therapy in Prostate Cancer.

肿瘤微环境在介导放射性药物治疗中的作用：连接核医学与肿瘤免疫治疗

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy.

双模态 PET/CT 与 PET/MRI 显像在多发性骨髓瘤/前列腺癌再分期及 BCMA 靶向 CAR-T 治疗疗效评估中的应用

Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessment.

前列腺癌细胞表面癌胚抗原：治疗潜力与放射性配体靶向

Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting.

CEACAM5、Trop-2、5T4、GPC3 和 ROR1 癌胚蛋白在晚期前列腺癌中表达各异。针对这些蛋白的治疗药物和放射性药物显像剂正在研发中。尽管已出现令人振奋的发现，但仍需大量临床研究来确定靶向这些蛋白的价值。

前列腺癌中基于 PSMA 的治疗的序贯与联合应用的新兴证据

Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer.

结合胶原的 IL-12 装甲 STEAP1 CAR-T 细胞降低毒性并在小鼠模型中治疗前列腺癌

Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse models.

前列腺癌 CAR-T 细胞治疗：当前进展与未来展望

CAR-T Cell Therapy for Prostate Cancer: Current Advances and Future Perspectives.

人源化 PSMA 靶向 CAR-T 细胞的工程化改造用于强效且特异性清除前列腺癌细胞

Engineering of Humanized PSMA-Directed CAR T Cells for Potent and Specific Elimination of Prostate Cancer Cells.

水凝胶微珠中的微生理实体瘤模型用于 CAR-T 细胞免疫治疗评价

Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation.

靶向表观基因组编辑诱导的 CAR-T 细胞中持久且特异的多重免疫检查点调控

Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing.